Log In Sign up
The largest database of trusted experimental protocols

Ifn α intron a

Manufactured by Merck Group
Visit Supplier

IFN-α (Intron A) is a laboratory product manufactured by Merck Group. It is a recombinant human interferon alpha-2b protein. Interferon alpha-2b is a type I interferon that has antiviral, antiproliferative, and immunomodulatory properties.

Automatically generated - may contain errors

Lab products found in correlation

Il 11, by Miltenyi Biotec (2 mentions) Interleukin 6 (il 6), by Miltenyi Biotec (2 mentions) Il 27, by R&D Systems (1 mentions)

Close spelling variants of this product

Intron A IFN-α

2 protocols using ifn α intron a

1

Cytokine Induction Experiment

Check if the same lab product or an alternative is used in the 5 most similar protocols
IL-6, IL-11, LIF, and OSM were purchased from Miltenyi Biotec. IL-27 was purchased from Bio-Techne, IL-6/IL-6R alpha was purchased from R&D Systems, and IFN-α (Intron A) was purchased from Merck. All cytokines were used at a final concentration of 100 ng/mL, with the exception of IFN-α, which was used at 105 U/mL.
Arlabosse T., Materna M., Riccio O., Schnider C., Angelini F., Perreau M., Rochat I., Superti-Furga A., Campos-Xavier B., Héritier S., Pereira A., Deswarte C., Lévy R., Distefano M., Bustamante J., Roelens M., Borie R., Le Brun M., Crestani B., Casanova J.L., Puel A., Hofer M., Fieschi C., Theodoropoulou K., Béziat V, & Candotti F. (2023). New Dominant-Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130-Dependent Hyper-IgE Syndrome. Journal of Clinical Immunology, 43(7), 1566-1580.
+ Open protocol
+ Expand
2

Cytokine Signaling Pathway Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
IL-6, IL-11, LIF, and OSM were purchased from Miltenyi Biotech. The IL-6–IL-6Rα fusion protein and IL-27 were purchased from R&D Systems. IFN-α (Intron A) was purchased from Merck. IL-6, IL-6–IL-6Rα, IL-11, IL-27, LIF, and OSM were all used at a final concentration of 100 ng/ml. IFN-α was used at a final concentration of 105 U/ml.
Béziat V., Tavernier S.J., Chen Y.H., Ma C.S., Materna M., Laurence A., Staal J., Aschenbrenner D., Roels L., Worley L., Claes K., Gartner L., Kohn L.A., De Bruyne M., Schmitz-Abe K., Charbonnier L.M., Keles S., Nammour J., Vladikine N., Maglorius Renkilaraj M.R., Seeleuthner Y., Migaud M., Rosain J., Jeljeli M., Boisson B., Van Braeckel E., Rosenfeld J.A., Dai H., Burrage L.C., Murdock D.R., Lambrecht B.N., Avettand-Fenoel V., Vogel T.P., Esther CR J.r., Haskologlu S., Dogu F., Ciznar P., Boutboul D., Ouachée-Chardin M., Amourette J., Lebras M.N., Gauvain C., Tcherakian C., Ikinciogullari A., Beyaert R., Abel L., Milner J.D., Grimbacher B., Couderc L.J., Butte M.J., Freeman A.F., Catherinot É., Fieschi C., Chatila T.A., Tangye S.G., Uhlig H.H., Haerynck F., Casanova J.L, & Puel A. (2020). Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. The Journal of Experimental Medicine, 217(6), e20191804.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!